Genmab — Juni 2020
-
Bispecifics er in og nu med CD28 https://finance.yahoo.com/news/publication-highlights-preclinical-research-showing-180000874.html
-
I 2006 kørte et forsøg med CD28 fuldstændigt af sporet med patienter der røg på intensiv og vist nok flere døde. Man er heldigvis kommet videre siden.
-
Har tjekket historien. Ingen døde, men oplevede voldsomme bivirkninger som var livstruende.
-
Forsøget medførte at Torben Plesner og Genmab var ekstremt forsigtige med doseringen da man startede forsøg op med daratumumab.
-
Community advice : SQ formulation of Daratumumab. ( transscript ) https://www.onclive.com/insights/daratumumab-subcutaneous-formulation-for-treatment-of-mm?eKey=amFuYm9ydXAxOTc4QGdtYWlsLmNvbQ==
-
God morgen.
-
Nikkei 225 i Tokyo faller 1,33 prosent
Kospi i Seoul faller 1,70 prosent
Singapore-børsen er ned 1,17 prosent
ASX 200 i Sydney faller 1,63 prosent -
-
** Credit Suisse downgrades Danish pharmaceutical company Genmab GMAB.CO to "neutral" from "outperform" after it had found a material error in the PharmaValues net present value (NPV) calculation for the company
** Due to the error, the value of cancer drug Darzalex and chronic lymphocytic leukemia antibody ofatumumab royalties to Genmab were overstated, the brokerage says
** CS says its revised Genmab PharmaValues Equity NPV is DKK 1,800/share, reduced from DKK2,300/share seen previously
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind